These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 14996484

  • 1. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Int J Cardiol; 2004 Mar; 94(1):111-7. PubMed ID: 14996484
    [Abstract] [Full Text] [Related]

  • 2. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [Abstract] [Full Text] [Related]

  • 3. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
    Ushiroyama T, Nosaka S, Ueki M.
    Int J Cardiol; 2006 Oct 26; 113(1):66-75. PubMed ID: 16356567
    [Abstract] [Full Text] [Related]

  • 4. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 26; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 5. Effects of atorvastatin therapy on the low-density lipoprotein subfraction, remnant-like particles cholesterol, and oxidized low-density lipoprotein within 2 weeks in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Circ J; 2003 Oct 26; 67(10):866-70. PubMed ID: 14578621
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 7. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
    Puccetti L, Bruni F, Bova G, Cercignani M, Palazzuoli A, Console E, Auteri A, Pasqui AL.
    Nutr Metab Cardiovasc Dis; 2001 Dec 10; 11(6):378-87. PubMed ID: 12055702
    [Abstract] [Full Text] [Related]

  • 8. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D.
    Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324
    [Abstract] [Full Text] [Related]

  • 9. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 27; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 10. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
    Lai WT, Lee KT, Chu CS, Voon WC, Yen HW, Tsai LY, Sheu SH.
    Int J Cardiol; 2005 Feb 28; 98(3):459-64. PubMed ID: 15708180
    [Abstract] [Full Text] [Related]

  • 11. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.
    Am Heart J; 2005 Mar 28; 149(3):473. PubMed ID: 15864218
    [Abstract] [Full Text] [Related]

  • 12. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
    Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, Le NA, Jones D, Quyyumi AA.
    J Clin Lipidol; 2012 Mar 28; 6(1):42-9. PubMed ID: 22264573
    [Abstract] [Full Text] [Related]

  • 13. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Am J Cardiol; 2004 Aug 15; 94(4):497-500. PubMed ID: 15325939
    [Abstract] [Full Text] [Related]

  • 14. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 15; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1495-501. PubMed ID: 19026303
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.
    Am Heart J; 2004 Jul 01; 148(1):e4. PubMed ID: 15215813
    [Abstract] [Full Text] [Related]

  • 17. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I.
    Eur J Clin Pharmacol; 2002 Nov 01; 58(8):501-6. PubMed ID: 12451426
    [Abstract] [Full Text] [Related]

  • 18. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 01; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 19. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV, Yegorova YV.
    Kardiol Pol; 2006 Jan 01; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [Abstract] [Full Text] [Related]

  • 20. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.